SLRC:NASDAQSLR Investment Corp. Analysis
Data as of 2026-08-02 - not real-time
$12.58
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
SLR Investment Corp. (SLRC) is trading at $12.58, well below its 20‑day and 50‑day SMAs (12.94 and 12.83) and the 200‑day SMA (14.47), with a bearish MACD histogram and an RSI of 41.5, suggesting short‑term downside pressure toward the identified support at $12.35. However, the stock offers a substantial upside potential of roughly 22% to the analyst consensus target around $15.5, supported by a low beta (0.53) that moderates market‑wide volatility exposure.
Fundamentally, SLRC appears markedly undervalued – its trailing P/E of 7.7 is less than half the industry average of 18.0, and its price‑to‑book of 0.69 sits below the $1 benchmark. The dividend yield is exceptionally high at 12.23%, but the 100% payout ratio and negative operating cash flow (-$72.9 M) raise concerns about sustainability. The balance sheet is leveraged, with a debt‑to‑equity of 115% and $1.14 B of debt versus $400 M of cash, contributing to a max drawdown of –27% over the recent period. Recent news highlights stable net interest income and NAV per share in Q4 2025, indicating resilience in a challenging private‑credit environment.
Fundamentally, SLRC appears markedly undervalued – its trailing P/E of 7.7 is less than half the industry average of 18.0, and its price‑to‑book of 0.69 sits below the $1 benchmark. The dividend yield is exceptionally high at 12.23%, but the 100% payout ratio and negative operating cash flow (-$72.9 M) raise concerns about sustainability. The balance sheet is leveraged, with a debt‑to‑equity of 115% and $1.14 B of debt versus $400 M of cash, contributing to a max drawdown of –27% over the recent period. Recent news highlights stable net interest income and NAV per share in Q4 2025, indicating resilience in a challenging private‑credit environment.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above the $12.35 support level
- Bearish MACD and RSI below 50 indicating limited near‑term upside
- High dividend yield but sustainability concerns
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation gap (P/E 7.7 vs industry 18.0, P/B 0.69)
- Analyst consensus target around $15.5 implies ~22% upside
- Low beta reduces market‑wide volatility exposure
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Elevated leverage (Debt/Equity 115%) and negative cash flow
- Dividend payout at 100% of earnings may pressure future distributions
- Business‑development‑company structure provides steady income but depends on credit market conditions
Key Metrics & Analysis
Financial Health
Revenue Growth-7.30%
Profit Margin41.80%
P/E Ratio7.7
ROE9.06%
ROA3.75%
Debt/Equity114.88
P/B Ratio0.7
Op. Cash Flow$-72972000
Free Cash Flow$-4630875
Industry P/E18.0
Technical Analysis
TrendNeutral
RSI41.5
Support$12.35
Resistance$13.37
MA 20$12.94
MA 50$12.83
MA 200$14.47
MACDBearish
VolumeStable
Fear & Greed Index92.88
Valuation
Target Price$15.38
Upside/Downside22.22%
GradeUndervalued
TypeValue
Dividend Yield12.23%
Risk Assessment
Beta0.53
Volatility22.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKWTS
Watts Water Technologies, Inc.
STOCKAMZN
Amazon.com, Inc.
STOCKBLK
BlackRock, Inc.
STOCKUSFD
US Foods Holding Corp.
STOCKUSAC
USA Compression Partners, LP
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.